(Q34268523)

1 August 2017

1 reference

title

Mechanism of the anticoagulant action of heparin (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

Björk I

1

1 reference

1 August 2017

Lindahl U

series ordinal

2

1 reference

1 August 2017

publication date

1 October 1982

1 reference

Molecular and Cellular Biochemistry

1 August 2017

published in

1 reference

1 August 2017

volume

48

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

161-182

1 reference

Degradation of heparin in mouse mastocytoma tissue

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00421226

Binding to antithrombin of heparin fractions with different molecular weights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00421226

The molecular-weight-dependence of the anti-coagulant activity of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00421226

A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00421226

Evidence for the formation of an ester between thrombin and heparin cofactor

21 January 2018

1 reference

12 December 2020

The separation of active and inactive forms of heparin

1 reference

12 December 2020

Fractionation of low molecular weight heparin species and their interaction with antithrombin

1 reference

12 December 2020

A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor

1 reference

12 December 2020

Binding of heparin on the surface of cultured human endothelial cells

1 reference

12 December 2020

Changes in numbers and heparin content of peritoneal fluid mast cells of growing rats measured by flow cytofluorometry

1 reference

12 December 2020

Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro

1 reference

12 December 2020

Antithrombin III and heparin

1 reference

12 December 2020

Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor

1 reference

12 December 2020

Anticoagulant Action of Heparin

1 reference

12 December 2020

The Size and Shape of Human and Bovine Antithrombin III

1 reference

12 December 2020

Altered inactivation of trinitrophenylated thrombin by antithrombin III in the presence of heparin

1 reference

12 December 2020

Further characterization of the antithrombin-binding sequence in heparin

1 reference

12 December 2020

Structure of the antithrombin-binding site in heparin

1 reference

12 December 2020

Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III

1 reference

12 December 2020

Fractionation of heparin by affinity chromatography on covalently-bound human α-thrombin

1 reference

12 December 2020

Some properties of antithrombin-III and its concentration in human plasma

1 reference

12 December 2020

Small doses of heparin and a new concept of hypercoagulability

1 reference

12 December 2020

The kinetics of formation and dissociation of the bovine thrombin.antithrombin III complex

1 reference

12 December 2020

The production of an inactive form of antithrombin through limited proteolysis by thrombin

1 reference

12 December 2020

A New Assay for the Measurement of Total Progressive Antithrombin

1 reference

12 December 2020

Isolation and properties of high molecular weight heparin

1 reference

12 December 2020

On the molecular-weight-dependence of the anticoagulant activity of heparin

1 reference

12 December 2020

Quantitative aspects of antithrombin and heparin in plasma

1 reference

12 December 2020

Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III

1 reference

12 December 2020

Biosynthesis of heparin. Concerted action of late polymer-modification reactions

1 reference

12 December 2020

Anti-Xa active heparin oligosaccharides

1 reference

12 December 2020

The isolation of heparin from mast cells of the normal rat

1 reference

12 December 2020

Enzymic depolymerization of macromolecular heparin as a factor in control of lipoprotein lipase activity

1 reference

12 December 2020

The interaction of thrombin and heparin. Proflavine dye binding studies.

1 reference

12 December 2020

Biosynthesis of heparin. Assay and properties of the microsomal N-acetyl-D-glucosaminyl N-deacetylase

1 reference

12 December 2020

Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis

1 reference

12 December 2020

Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction

1 reference

12 December 2020

In vitro and in vivo correlation of clotting protease activity: Effect of heparin

1 reference

12 December 2020

Chemistry of the hemostatic mechanism and its relationship to the action of heparin

1 reference

12 December 2020

A proteoglycan form of heparin and its degradation to single-chain molecules

1 reference

12 December 2020

Influence of ionic strength and pH on the interaction between high-affinity heparin and antithrombin

1 reference

12 December 2020

Specific coagulation factor adsorption to insoluble heparin

1 reference

12 December 2020

The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies

1 reference

12 December 2020

Detection of a new heparin-dependent inhibitor of thrombin in human plasma

1 reference

12 December 2020

Structure-function relationships of heparin species

1 reference

12 December 2020

Heparin reacts stoichiometrically with thrombin during thrombin inhibition in human plasma

1 reference

12 December 2020

Heparin and the inactivation of thrombin by antithrombin III.

1 reference

12 December 2020

[Investigations on the mechanism of the antithrombin effect of heparin]

1 reference

12 December 2020

The binding of low molecular weight heparin to hemostatic enzymes

1 reference

12 December 2020

Properties of the factor Xa binding site on human platelets

1 reference

12 December 2020

The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups

1 reference

12 December 2020

An antithrombin reaction to prothrombin activation.

1 reference

12 December 2020

The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor

1 reference

12 December 2020

The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin

1 reference

12 December 2020

Structural studies of the carbohydrate moiety of human antithrombin III

1 reference

12 December 2020

Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin

1 reference

12 December 2020

Action of heparin on thrombin-antithrombin reaction

1 reference

12 December 2020

Effect of heparin on thrombin inactivation by antithrombin-III.

1 reference

12 December 2020

A new type of heparin "omega-heparin" isolated from whale organs

1 reference

12 December 2020

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration

1 reference

12 December 2020

Slow, spontaneous dissociation of the antithrombin-thrombin complex produces a proteolytically modified form of the inhibitor.

1 reference

12 December 2020

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

1 reference

12 December 2020

The covalent nature of the human antithrombin III--thrombin bond

1 reference

12 December 2020

Macrophages produce blood coagulation factors

1 reference

12 December 2020

Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin

1 reference

12 December 2020

Mechanism of action of heparin through thrombin on blood coagulation

1 reference

12 December 2020

Studies on the binding of heparin to prothrombin and thrombin and the effect of heparin-binding on thrombin activity

1 reference

12 December 2020

The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin

1 reference

12 December 2020

Studies on the interaction of heparin with thrombin, antithrombin, and other plasma proteins

1 reference

12 December 2020

Studies on the Mechanism of the Rate-Enhancing Effect of Heparin on the Thrombin-Antithrombin III Reaction

1 reference

12 December 2020

The concept of macromolecular heparin and its physiological significance

1 reference

12 December 2020

Biological Properties of the Naturally Occurring Plasma Inhibitor to Activated Factor X

1 reference

12 December 2020

The binding of low-affinity and high-affinity heparin to antithrombin. Competition for the same binding site on the protein

1 reference

12 December 2020

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

1 reference

12 December 2020

Inhibition of activated factor XII by antithrombin-heparin cofactor

1 reference

12 December 2020

The site in human antithrombin for functional proteolytic cleavage by human thrombin

1 reference

12 December 2020

Proteinase activity in macrophage cultures. Effects of heparin and antithrombin

1 reference

12 December 2020

Evidence by Chemical Modification for the Involvement of One or More Tryptophanyl Residues of Bovine Antithrombin in the Binding of High-Affinity Heparin

1 reference

12 December 2020

Low doses of heparin in prevention of deep-vein thrombosis

1 reference

12 December 2020

The binding of 1-anilino-8-naphthalenesulfonate, heparin, salicylate and caprylate by human antithrombin III

1 reference

12 December 2020

The role of heparin in the thrombin-antithrombin III reaction

1 reference

12 December 2020

Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III

1 reference

12 December 2020

Metabolism of macromolecular heparin in mouse neoplastic mast cells

1 reference

12 December 2020

Purification of thrombin by affinity chromatography on immobilized heparin

1 reference

12 December 2020

Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma

1 reference

12 December 2020

Heparin-like anticoagulants from Mollusca

1 reference

12 December 2020

Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III-thrombin complex

1 reference

12 December 2020

Binding of high affinity heparin to antithrombin III. Characterization of the protein fluorescence enhancement

1 reference

12 December 2020

Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex

1 reference

12 December 2020

Studies in man and experimental animals of a low molecular weight heparin fraction

1 reference

12 December 2020

The inhibition of activated bovine coagulation factors X and VII by antithrombin III.

1 reference

12 December 2020

Anticoagulant activity of heparin: isolation of antithrombin-binding sites

1 reference

12 December 2020

The heparin-thrombin complex in the mechanism of thrombin inactivation by heparin

1 reference

12 December 2020

A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro

1 reference

12 December 2020

The inhibition of human plasmin by human antithrombin-heparin cofactor.

1 reference

12 December 2020

1 reference

12 December 2020

Lymphocyte cooperation is required for amplification of macrophage procoagulant activity

1 reference

12 December 2020

Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration

1 reference

12 December 2020

The antithrombin-binding sequence of heparin studied by n.m.r. spectroscopy

1 reference

12 December 2020

The inactivation of thrombin and plasmin by antithrombin III in the presence of Sepharose-heparin

1 reference

12 December 2020

Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor

1 reference

12 December 2020

Tissue specific distribution of sulfated mucopolysaccharides in mammals

1 reference

12 December 2020

The interaction of heparin with human α-thrombin: Effect on the hydrolysis of anilide tripeptide substrates

1 reference

12 December 2020

Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence

1 reference

12 December 2020

Biosynthesis of heparin. Studies on the microsomal sulfation process

1 reference

12 December 2020

Effect of heparin-binding to thrombin on thrombin activity measured with a chromogenic substrate

1 reference

12 December 2020

Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin

1 reference

12 December 2020

Release of a Two-Chain Form of Antithrombin from the Antithrombin-Thrombin Complex

1 reference

12 December 2020

Binding of heparin to antithrombin III: The use of dansyl and rhodamine labels

1 reference

12 December 2020

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

1 reference

12 December 2020

Active site of alpha 1-antitrypsin: homologous site in antithrombin-III

1 reference

12 December 2020

Distribution of sulfated mucopolysaccharides in invertebrates

1 reference

12 December 2020

Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III

1 reference

12 December 2020

A novel 3-O sulfatase from human urine acting on methyl-2-deoxy-2-sulfamino-alphs-D-glucopyranoside 3-sulfate

1 reference

12 December 2020

Multiple functional domains of the heparin molecule

1 reference

12 December 2020

Inhibition of human factor IXa by human antithrombin

1 reference

12 December 2020

Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies

1 reference

12 December 2020

Structure and biosynthesis of heparin-like polysaccharides

1 reference

12 December 2020

Evidence for a heparin-induced conformational change on antithrombin III

1 reference

12 December 2020

Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin

1 reference

12 December 2020

Native heparin from rat peritoneal mast cells

1 reference

12 December 2020

Anticoagulant Activity of Heparin Octasaccharide1

1 reference

12 December 2020

Covalent modification of human alpha-thrombin with pyridoxal 5'-phosphate. Effect of phosphopyridoxylation on the interaction of thrombin with heparin

1 reference

12 December 2020

Inhibition of the heparin-antithrombin III/thrombin reaction by active site blocked-thrombin

1 reference

12 December 2020

Characterization of human, bovine, and horse antithrombin III

1 reference

12 December 2020

The molecular size of the antithrombin-binding sequence in heparin

1 reference

12 December 2020

Correlation between structure and function of heparin

1 reference

12 December 2020

Conformational changes accompanying the binding of antithrombin III to thrombin

1 reference

12 December 2020

A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation

1 reference

12 December 2020

Highly active heparin species with multiple binding sites for antithrombin

1 reference

12 December 2020

Heparin and protease inhibition. I. Heparin complexes with thrombin, plasmin, and trypsin

1 reference

12 December 2020

Heparin binding to antithrombin III: variation in binding sites and affinity

1 reference

12 December 2020

The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue

1 reference

12 December 2020

Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin

1 reference

12 December 2020

Small-angle x-ray scattering studies on human antithrombin III and its complex with heparin

1 reference

12 December 2020

Immunological evidence for a proteolytic cleavage at the active site of antithrombin in the mechanism of inhibition of coagulation serine proteases

1 reference

12 December 2020

Decreased Heparin Sensitivity of Cyclohexanedione-Modified Thrombin

1 reference

12 December 2020

Glycosaminoglycans and Their Binding to Biological Macromolecules

1 reference

12 December 2020

The assay and partial characterization of macromolecular heparin depolymerase activity in rat small intestine

1 reference

12 December 2020

Studies on the Antithrombin and Heparin Co-factor Activities of a Fraction Adsorbed from Plasma by Aluminum Hydroxide

1 reference

12 December 2020

The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin

1 reference

12 December 2020

Tryptophan residue at the heparin binding site in antithrombin III

1 reference

12 December 2020

Dissociation of antithrombin III--thrombin complex. Formation of active and inactive antithrombin III.

1 reference

12 December 2020

Isolation and Characterization of Antithrombin III from Human, Porcine and Rabbit Plasma, and Rat Serum

1 reference

12 December 2020

The thrombin cleavage site in bovine antithrombin

1 reference

12 December 2020

Structural studies on the carbohydrate portion of human antithrombin III

1 reference

12 December 2020

The identity and origin of the anticoagulant of anaphylactic shock in the dog

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00421226

1 reference

Dimensions Publication ID

1 August 2017

1007758246

0 references

1 reference